Using a special PET scan to detect invasive fungal infections
Official title: Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
Run by Peter MacCallum Cancer Centre, Australia · NCT06105411 · Data updated 2026-11-12
This study is testing a special PET scan with a new tracer to see if it can help find invasive fungal infections in people who have recently been diagnosed.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Peter MacCallum Cancer Centre, Australia Academic / other |
| Locations | 1 site (Melbourne, Victoria) |
| Status | Recruiting |
| Started | December 1, 2023 |
| Main results expected | October 2026 |
| Study ends | April 2027 |
| Registry record updated | September 5, 2025 |
| Trial ID | NCT06105411 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 years or older who have been diagnosed with invasive fungal infections within two weeks.
✕Probably not a fit
Patients who are pregnant, lactating, or have received iron infusion within one week prior to the scan may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational pilot trial aims to evaluate the effectiveness of a gallium-siderophore tracer in identifying areas of invasive Aspergillus infection in patients. It will involve 10 participants who have been diagnosed with invasive fungal infections within the last two weeks. The study will assess the localized uptake of the tracer using a 68Ga-labelled TAFC PET/CT scan, while also monitoring the safety and tolerability of this imaging technique. The trial is conducted at a single center over a period of 12-24 months.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic accuracy for invasive fungal infections, allowing for timely and appropriate treatment.
How similar studies have gone: While this approach is innovative, it is still in the proof of concept phase and has not been widely tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient has provided written informed consent 2. Aged 18 years or older at written informed consent 3. Within 2 weeks of proven or probable or possible invasive fungal infection (IFI) diagnosis as per EORTC criteria 4. Imaging consistent with invasive pulmonary aspergillosis on CT or FDG-PET/CT with lesions at least 8mm in diameter 5. Patient is willing and able to comply with the protocol for the duration of the study including scheduled visits such as follow up Exclusion Criteria: 1. Women who are pregnant or lactating. 2. Iron infusion within one week prior to scan
Where it's running
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia Recruiting
Study contacts
- Study coordinator: Abby Douglas
- Email: Abby.Douglas@petermac.org
- Phone: 03 855 96136
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-dose Liposomal Amphotericin B for preventing fungal infections in adults with blood cancers and prolonged neutropenia
This study tests whether giving a daily 50 mg dose of liposomal amphotericin B can help prevent invasive fungal infections in adults with blood cancers who have prolonged low white blood cell counts.
-
Low-dose liposomal amphotericin B to prevent invasive fungal infections in neutropenic children
This study tests whether giving a fixed low dose of liposomal amphotericin B can prevent invasive fungal infections in children aged 3–17 who are severely neutropenic after hematopoietic stem cell transplantation or similar high-risk conditions.
-
Breath analysis to detect fungal infections in leukemia patients
This study is testing if analyzing breath samples can help doctors detect fungal infections in leukemia patients who are at high risk due to their treatment.
-
Evaluating the role of PET-CT in managing invasive fungal infections
This study is testing if a special type of scan called PET-CT can help doctors better manage invasive fungal infections compared to regular imaging methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.